Catalyst
Slingshot members are tracking this event:
IPF: Inhaled αvβ6 inhibitor Phase IIa anticipated to start in 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GSK | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 21, 2018
Occurred Source:
https://clinicaltrials.gov/ct2/show/NCT03573505
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Αvβ6 Inhibitor, Phase 2a
